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Neurotrophins are a group of secreted polypeptides, which comprises Nerve Growth Factor (NGF)
and Brain-Derived Neurotrophic Factor (BDNF). Each neurotrophin can bind speciﬁcally to a tyrosine
kinase Trk receptor (TrkA, TrkB or TrkC), while all of the neurotrophins can bind, with similar afﬁn-
ity, to the p75 neurotrophin receptor (p75NTR). Experiments on cell viability promotion by BDNF in
granule neurons or by NGF in PC12 cells show that neurotrophin-exerted cell viability is neutral
sphingomyelinase (nSMase)-dependent, since GW4869 or siRNA knockdown abrogates the protec-
tive effects, as well as neurotrophin-induced Akt phosphorylation. Finally, the assessment of nSMase
activity promotion drives to the conclusion that neurotrophins can promote cell viability through
Trk receptors in a manner depending on basal nSMase but not through SMase activity enhancement.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mammalian neurotrophins (NTs) are a group of secreted poly-
peptides, which comprises Nerve Growth Factor (NGF), Brain-De-
rived Neurotrophic Factor (BDNF), Neurotrophin-3 (NT-3) and
Neurotrophin-4/5 (NT-4/5). NTs act as dimmers on target cells by
means of their interaction with transmembrane receptors, activat-
ing a set of signaling cascades and modulating the development
and maintenance of the vertebrate nervous system. Each NT binds
speciﬁcally to a tyrosine kinase Trk (tropomyosin-related kinase)
receptor (NGF binds to TrkA, BDNF to TrkB, NT-3 mainly to TrkC
and NT-4/5 also to TrkB), while all of them can bind, with similar
afﬁnity, to the p75 Neurotrophin Receptor (p75NTR). The role of
Trk receptors in neuronal survival, differentiation and function is
well-deﬁned, including activation of signaling pathways (PI3K-Akt, ras-ERK-1/2 and PLCc-PKC) [See [1] for a review]. In contrast,
the function mode of p75NTR has not been clearly deﬁned. p75NTR is
included in the Tumor Necrosis Factor Receptor (TNFR) superfam-
ily [2], whose members lack intrinsic enzymatic activity, and sig-
naling occurs through association with adaptor proteins to
mediate diverse cellular functions, such as apoptosis, survival or
axonal growth, depending on the cellular context. Thus, the
p75NTR intracellular domain (ICD) contains several regions likely
to mediate interactions with downstream signaling elements [3].
These proteins have been largely isolated using yeast two-hybrid
screening and include NRAGE (neurotrophin-interacting MAGE
homolog) [4], NADE (p75NTR associated cell-death executor), TRAF
(TNF receptor-associated factor) proteins [5] and NRIF 1 and 2
(Neurotrophin receptor interacting factor) [6]. Additionally, the
extracellular domain of p75NTR can interact with other membrane
proteins, as is the case of the aforementioned Trk receptors [7],
altering Trk docking subdomains [8].
An ability of p75NTR, which is shared with some members of the
TNFR family, is the induction of sphingomyelin hydrolysis and the
increase of cellular ceramide levels, after the binding of its ligands
[9], the aforementioned hydrolysis being a consequence of sphin-
gomyelinase activity promotion [10]. It has been demonstrated
that ceramide, and its related metabolites, acts as a second mes-
senger, being involved in apoptosis [11] as well as in cell survival
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JNK [13] or ERK-1/2 [14] or, on the other hand, of phosphatases
PP1 and PP2A [15]. Several enzymes with SMase activity have been
described, the neutral (nSMase) and the acid sphingomyelinases
(aSMase) being the most studied [16]. Despite extensive studies,
the precise cellular function of each of these sphingomyelinases
in sphingomyelin turnover and in the regulation of ceramide-med-
iated responses is not well understood. In mammals, three Mg2+-
dependent neutral SMases have been identiﬁed (nSM1, nSM2 and
nSM3). Among the three enzymes, nSMase2 is the most studied
and has been involved in some physiological responses including
apoptosis, development and inﬂammation [17]. In addition, recent
studies have also supported a role for SMase activity in membrane
trafﬁcking, suggesting that nSMase2 may act in the endosomal
compartments giving rise to multivesicular endosomes through
formation of intravesicular membranes [18]. Recently, the exis-
tence if a ‘‘sphingolipid rheostat’’ has been postulated [19], a mech-
anism based on the fact that sphingosine-1-phosphate and
ceramide are biologically interconvertible lipids [20], determining
their relative levels the cell fate (life or death) [21]. Moreover, a
prominent role of SMase activity in endocytosis has also been
extensively postulated, in physiological conditions [22] as well as
in pathogen invasion [23].
Another p75NTR-dependent signaling event is Akt phosphoryla-
tion, which occurs in a variety of cell types in a TrkA-independent
manner [24]. Moreover, p75NTR expression increased survival in
cells exposed to stress, indicating that p75NTR facilitates cell sur-
vival through novel signaling cascades involving Akt activation
[24]. Apart from the synergic action of Trk and p75NTR, published
evidences also suggest an inhibitory activity of TrkA on p75NTR-
mediated signaling, in some cases. An example supporting this
hypothesis is the cross-talk between p75NTR and the TrkA signaling
pathway demonstrated in the case of the sphingomyelin hydrolysis
induced by NGF [25]. Thus, while co-expression of TrkA with
p75NTR abolished p75NTR-dependent sphingomyelin hydrolysis,
inhibition of TrkA activity with K252a enhanced p75NTR-mediated
sphingomyelin hydrolysis in PC12 cells, thus further supporting
the modulatory role of TrkA on p75NTR signaling [25]. Additionally,
p75NTR can activate NFkB signaling, the time-course of NF-kB acti-
vation being very slow in PC12 cells (approx. 1 h), and probably
due to the modulatory activity of TrkA on p75NTR signaling [26].
In accordance with this, it has been demonstrated that in rat Schw-
anoma cells, which express p75NTR but not TrkA, activation of NFkB
occurs within 30 min [27], more rapidly than in PC12 cells [26].
Also, in the case of the proneurotrophin proNGF, a cross-talk mech-
anism between neurotrophin receptors has been described. ProN-
GF induces an inhibitory effect of p75NTR on TrkB signaling
through the activation of PTEN (phosphatase and tensin homolog
delete on chromosome 10) phosphatase, causing abrogation of
the Akt pathway [28]. In accordance with the aforementioned liter-
ature, we have studied the use of nSMase by both TrkA and TrkB
receptors to yield cell survival.2. Materials and methods
2.1. Cellular cultures
Cerebellar granule neuron (CGN) cultures were prepared as de-
scribed [42]. PC12 cells were cultured in Dulbecco’s modiﬁed Ea-
gle’s medium (DMEM) supplemented with 10% horse serum, 5%
fetal calf serum, 50 U/ml penicillin and 50 lg/ml streptomycin, at
37 C in a humidiﬁed 5% CO2 atmosphere. For experiments, cells
were seeded at a density of 7  104 cells/cm2 in plates coated with
10 lg/ml poly-L-lysine. Cells were left overnight before starting
experimental treatments. PC12 differentiation was achieved byaddition of NGF 50 ng/ml (Sigma–Aldrich) for seven days, with
change of medium at DIV3. BDNF was also purchased from Sig-
ma–Aldrich, while the nSMase inhibitor GW4869 was obtained
from Calbiochem. For siRNA knockdown assays, PC12 cells were
cultured for 24 h, and siRNA was transfected using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instructions.
Cells were transfected with functional, non-targeting control siRNA
(All Stars Negative Control from Qiagen) or a mix of four pre-de-
signed nSMase2-speciﬁc Flexitube siRNAs against the smpd3 gen
(Qiagen). For each well, 20 pmol of each siRNA was added. After
15 min at room temperature, lipid and the siRNA mixture was
added to each well containing cells. Cells were then incubated
for an additional 72 h prior to the experiments. Decrease of the
nSMase-2 protein expression was assessed by means of Western
blot using a monoclonal antibody raised against amino acids
461–655 mapping at the C-terminus of nSM2 of human origin
(Santa Cruz, antibody G-6). This region shows very little homology
with nSM1 and nSM3.
2.2. Measurement of cell viability
Cell viability was determined by using the conventional 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
reduction assay. In the MTT assay, the viable cells convert cell-per-
meable soluble dye MTT to insoluble blue formazan crystals and
this reaction is catalyzed by the succinate dehydrogenase, a mito-
chondrial respiratory-chain enzyme easily inactivated by oxidative
stress. After incubation with the indicated chemicals, cells were
treated with MTT solution (1 mg/ml ﬁnal concentration) for 2 h
at 37 C. The dark blue formazan crystals formed inside the intact
mitochondria were solubilized with dimethylsulfoxide, and the
absorbance of the blue color was measured at 570 nm using a
microplate reader (TECAN GmbH; Salzburg, Austria).
2.3. Hoechst staining assay
PC12 cells were seeded in 24-well plates at 5104 cells/well and
treated with hoechst ﬂuorochrome (100 lg/mL) for 5 min at 37 C
in dark. Hoechst-stained nuclei were observed by using a ﬂuores-
cence microscope (Nikon, Japan) at an excitation wavelength of
350 nm and an emission wavelength of 460 nm. A total of 100 cells
from 30 random high power ﬁelds were counted. The percentage of
apoptosis was expressed as ratio of apoptotic cells to total cells.
2.4. Measurement of caspase-3 activity
The activity of caspase-3 like protease in the lysate was mea-
sured using a colorimetric caspase-3 assay. In brief, the reaction
mixture (total volume, 100 lL) contained 25 lL of cell lysate and
50 lL of caspase-3 substrate acetyl-Asp-Glu-Val-Asp-AMC (ﬁnal
concentration, 200 lM) in assay buffer, and the assay was carried
out in 96-well plate. Mixtures were incubated for 5 h at 37 C
and the absorbance was read at 405 nm. Each caspase-3 activity
was expressed as percentage respect to non-deprived cells.
2.5. Sphingomyelinase activity analysis
After treatment, cells were harvested with 500 ll of 1  reac-
tion buffer (Tris–HCl 0.1 M, pH 7.4, 10 mM MgCl2, 1% Triton
X-100 and protease/phosphatase inhibitors), sonicated and centri-
fuged at 9000g for 30 min at 4 C. The supernatant fraction was
used for neutral sphingomyelinase (nSMase) activity determina-
tion using the Amplex Red Sphingomyelinase Assay Kit, according
to the manufacturer’s instructions (Molecular Probes, Invitrogen).
Fluorescence was determined with a Series BioAssay Reader
(Perkin Elmer Instruments; Waltham, MA, USA).
***
**
(A) CGN
150
200
vs
K5
*
0
50
100
M
TT
 %
 v
-K25 BDNF BDNF
+GW
GW NGF
K5
(B) PC12
******
150
200
s
de
pr
iv
ed
-
****
0
50
100
M
TT
 %
 v
s
BDNF GWNGFNGFBDC
+GW +GWNF
Serum deprived
Fig. 1. Neurotrophin-dependent protection of CGN and of PC12 in front of cell death
depends on nSMase activity. (A) CGN cells were grown for seven DIV in 25 mM KCl
medium. BDNF or NGF (50 ng/ml both) was added 30 min before switching the
medium from a medium with 25 mM KCl (K25) to a medium with 5 mM KCl (K5),
and maintained for 24 h. The nSMase activity was inhibited, where indicated, by
adding GW4869 10 lM 1 h before BDNF. After this time, cell viability was estimated
by the MTT assay, as stated in Section 2. ⁄P < 0.05, ⁄⁄P < 0.01 and ⁄⁄⁄P < 0.001, when
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After treatment, cells were resuspended in 0.5 ml of homogeni-
zation buffer containing 20 mM Tris/HCl (pH 7.5), 2 mM EDTA,
0.5 mM EGTA, 2 mM DTT, 1 mM Na3VO4, 50 mM NaF, 2 mM PMSF,
10 lg/ml leupeptin and 25 lg/ml aprotinin and disrupted by soni-
cation in a Dynatech Sonic Dismembrator. Each sample was ana-
lyzed by SDS/PAGE and Western blotting. The separated proteins
were transferred to Protran nitrocellulose membrane (Schleicher
and Schuell; Dassel, Germany), using a Mini TransBlot Cell 3
(Bio-Rad; Hercules, CA, USA) at 100 V for 1 h. The blotting buffer
contained 25 mM Tris, 200 mM glycine and 10% (v/v) methanol.
The membrane ﬁlters were blocked for 1 h with Tris-buffered sal-
ine, supplemented with 0.1% Tween 20 and 5% (w/v) defatted pow-
dered milk. Then the membranes were incubated overnight with
the corresponding antibody diluted in blocking buffer. Antibodies
against actin and tubulin were purchased by Sigma–Aldrich. Anti-
bodies against phS473Akt, phT308Akt, total Akt, phT202/Y204
ERK-1/2, total ERK-1/2 and php38 were obtained from Cell Signal-
ing Technology (Beverly, MA, USA). Antibody against TrkA was
from Upstate Biotechnology (Lake Placid, NY, USA). Antibodies
against TrkB and against phY705 Trk were from Abcam (Cam-
bridge, UK). Next, the membrane ﬁlters were incubated for 1 h
with a secondary antibody conjugated with horseradish peroxidase
diluted in blocking buffer. Several washes with Tris-buffered sal-
ine/0.1% Tween 20 were performed between all of the steps. The
Western blots were developed using detection reagents from
Amersham Pharmacia Biotech (Little Chalfont, Buckinghamshire,
UK) and visualized using a GeneGnome HR chemiluminescence
detection system coupled to a CCD camera (Syngene; Cambridge,
UK). When required, quantiﬁcation of the bands was performed
with the GeneTools program (Syngene; Cambridge, UK), which is
able to detect saturated signals. Only non-saturated signals were
used for quantiﬁcation purposes.compared with neurons switched to K5 medium, using one-way ANOVA, followed
by Bonferroni’s post hoc test. (B) PC12 cells were seeded overnight, and BDNF or
NGF (50 ng/ml both) was added 30 min before switching the medium to a serum-
free medium, and maintained for 24 h. The nSMase activity was inhibited by adding
GW4869 10 lM 1 h before the addition of each neurotrophin. Cell viability was
estimated by the MTT assay. ⁄⁄P < 0.01 and ⁄⁄⁄P < 0.001, when compared with cells
deprived and without any additional treatment, using one-way ANOVA, followed by
the Bonferroni’s post hoc test.3. Results
3.1. nSMase activity is essential for the prosurvival effect of
neurotrophins in CGN and in PC12 cells
CGN survival is dependent on the membrane potential inﬂu-
enced by the potassium concentration in the medium. Thus, a high
potassium concentration in the medium (25 mM, indicated as K25)
is necessary to maintain the cultures, but neuronal death occurs in
the medium containing low potassium concentrations (5 mM, indi-
cated as K5), even in the presence of serum. Thus, the previous re-
sults showing the nSMase dependence of prosurvival signaling,
such as Akt, were corroborated by measuring neuronal viability
by means of the MTT reduction assay (Fig. 1A). Potassium with-
drawal for 24 h induces the loss of CGN viability, which is highly
restored by BDNF, but not by NGF. The prosurvival effect exerted
by BDNF is abolished when cells are pretreated with GW4869, a
nSMase inhibitor. Moreover, the slight but signiﬁcant additional
decrease observed in MTT reduction due to GW4869 alone is inter-
esting, pointing to a role of basal nSMase activity in cellular viabil-
ity. Additionally, experiments of cell survival in PC12 inducing cell
death by means of serum deprivation show an absence of prosur-
vival activity of BDNF, as expected due to the lack of TrkB recep-
tors, but a clear effect of NGF, which is also totally dependent on
nSMase activity (Fig. 1B). Again, an additional decrease observed
in the MTT reduction due to GW4869 alone is observed, as in
CGN (Fig. 1A). In order to corroborate the role of nSMase activity
in neurotrophin-caused cell protection, the expression of nSM-
ase-2 (nSM2) in PC12 cells was abrogated by means of a siRNA pro-
tocol. Western blots of extracts from cells transfected with siRNAtargeting the smpd3 gene show a clear decrease in nSM2 protein
(Fig. 2A). A faint band of slightly higher molecular weight remains
in the siRNA treated cells, which probably corresponds to an
unspeciﬁc detection (Fig. 2A). Then, the same kinds of experiments
shown in the Fig. 1B were conducted. Results show that abrogation
of nSM2 expression in PC12 cells impairs the induction of viability
under deprivation stress induced by NGF (Fig. 2B), thus conﬁrming
the important role of nSMase activity in NGF-induced viability of
PC12 cells. In order to corroborate the results shown in Fig. 2, cas-
pase 3 activity and nuclei condensation were assessed, since serum
deprivation is described to cause apoptotic death. The silencing of
nSM2 protein with siRNA renders NGF unable to reverse the cas-
pase 3 activity induced by serum withdrawal (Fig. 3A). Moreover,
the determination of nuclear condensation with Hoechst staining
reinforces the results obtained in the section A, since the results
show that NGF action on the prevention of apoptotic nuclei is abol-
ished by nSM2 silencing (Fig. 3B and C). In summary, nSM2 is
essential in the NGF-induced protection against serum deprivation.
3.2. TrkB-induced Akt signaling in CGN strongly depends on nSMase
In order to further study the role of nSMase in prosurvival
events, cultures of primary cultures of granule neurons (CGN) were
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from three independent experiments. ⁄⁄P < 0.01, using one-way ANOVA, followed
by the Bonferroni’s post hoc test.
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Fig. 3. The effect of siRNA knockdown of nSM2 expression on NGF-induced
prevention of apoptotic events in PC12 cells under serum deprivation stress. (A)
nSM2 protein has a role in the NGF-induced negative control of caspase 3 activity
induced by serum deprivation. ⁄P < 0.05, ⁄⁄P < 0.01, ns: non-signiﬁcant, using one-
way ANOVA, followed by the Bonferroni’s post hoc test. (ND, non-deprived). (B)
Condensed nuclei were visualized by means of Hoechst staining and the percent-
ages of apoptotic nuclei were measured. The results show that nSM2 clearly
participates in the NGF-dependent prevention of the apoptotic death caused by
serum deprivation. ⁄⁄⁄P < 0.001, using one-way ANOVA, followed by the Bonfer-
roni’s post hoc test. (C) Representative images of the results shown in B. White
arrowheads show condensed nuclei. (ND, non-deprived; NT, non-transfected,
without NGF; NT+, non-transfected, with NGF; CSi, control siRNA, without NGF;
CSi+, control siRNA, with NGF; Nsi, nSM2 siRNA, without NGF; Nsi+, nSM2 siRNA,
with NGF).
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TrkC, but not TrkA [29]. When phosphorylation of Akt in Ser 473
and in Thr 308 in CGN is detected in CGN by Western blot, no
enhancing after NGF treatment (50 ng/mL, 15 min) is observed,
but rather a strong increase after BDNF (50 ng/mL, 15 min) is de-
tected. This increase is highly dependent on basal nSMase activity,
since GW4869 abolishes Akt phosphorylation in both residues in-
duced by BDNF (Fig. 4A and B). This result is in strong agreement
with the nSMase dependence of the BDNF-induced cell viability
shown in Fig. 1A. In parallel, it is observed that NGF does not in-
duce ERK-1/2 phosphorylation in residues Thr202 and Tyr204,
but GW4869 alone induces a signiﬁcant increase in the phospho-
ERK-1/2 signal, indicating that the basal nSMase activity, or nSM-
ase-dependent mechanisms, silences the ERK-1/2 pathway. On
the contrary, BDNF triggers ERK-1/2 phosphorylation, which is
not signiﬁcantly impaired by GW4869 treatment (Fig. 4C and D).
Regarding phosphorylation of p38 in Thr180 and Tyr182, NGF
has no effect, but BDNF does induce a moderate but consistent in-
crease, which is nSMase-independent, since GW4869 has no effect
on p38 phosphorylation (Fig. 4E and F).
3.3. NGF induces ceramide production only when Trk receptor activity
is not present
The p75NTR receptor exerts its functions by the binding of adap-
tor proteins and subsequent enhancement of enzymatic activities,
SMase activity being one of them, leading to the increase of the
ceramide/sphingomyelin (Cer/SM) ratio [9]. In consequence, after
the observation that neurotrophin-promoted survival depends on
nSMase, the activation of nSMase activity by NGF was assessed.
Treatment of CGN (a TrkA/TrkB+/p75NTR+ system) with NGF in-
duces nSMase activity, but not with BDNF (Fig. 5A). Treatment with
GW4869 alone induces a decrease in the basal nSMase activity.Action of BDNF on TrkB is monitored by means of detection of
Trk receptors phosphorylated in tyrosine 705 (Fig. 5A). On the
other hand, the Cer/SM ratio after acute NGF treatment was deter-
mined in NGF-differentiated PC12 cells (a TrkA+/TrkB/p75NTR+
system) for seven DIV or in an alternative condition without NGF
differentiation. The results show that cells respond to acute NGF
treatment, in terms of an increase in the Cer/SM ratio, only when
PC12 cells are NGF-differentiated. The absence of functional TrkA
receptor in the NGF-differentiated cells is corroborated by means
of Western blot against Trk phosphorylated in tyrosine 705, which
is related to Trk receptor activation (Fig. 5B). Thus, neurotrophins
induce cell viability through Trk receptors in a manner depending
on basal nSMase activity but not through promotion of nSMase. On
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Fig. 5. Absence of Trk activity correlates with an increase of ceramide levels
promoted by NGF. (A) CGNs were incubated with 50 ng/ml NGF, with or without co-
treatment with GW4869, a speciﬁc nSMase inhibitor. Alternatively, CGN were also
treated with 50 ng/ml BDNF. SMase activity was measured at pH 7.5 using the
Amplex Red Sphingomyelinase Assay Kit in each case. Each point represents the
mean ± S.D. of three independent experiments. Values were analyzed using one-
way ANOVA, followed by Dunnett’s post hoc test. ⁄⁄⁄P < 0.001. In parallel, the
activity of Trk receptors was monitored in the different treatments, using a
phosphospeciﬁc antibody against phosphoTyr 705, as well as total levels of TrkB
protein. (B) The ceramide/sphingomyelin ratio (Cer/SM) was assessed, as stated in
the Section 2, after acute NGF treatment for 1 h, in both NGF-differentiated and in
non-differentiated PC12 cells. An increase was detected only in NGF-differentiated
cells. The data shown are the mean ± S.D. of three experiments. The values were
analyzed by one-way ANOVA followed by the Bonferroni post hoc test to compare
NGF-treated cells, with respect to control. ⁄⁄P < 0.01. In parallel, the activity of Trk
receptors was monitored in the different treatments, using a phosphospeciﬁc
antibody against phosphoTyr 705, as well as total levels of TrkA protein.
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with prevention of the p75NTR-dependent nSMase activity (Fig. 5B).3.4. nSM2 knockdown impairs basal Akt phosphorylation,
but not ERK-1/2 phosphorylation
As demonstrated above, neurotrophins need nSMase activity to
induce prosurvival events, but without any enhancing of this enzy-
matic activity. In consequence, we aimed to determine whether
basal nSMase activity in PC12 is implicated in Akt phosphorylation.
Western blots of extracts from naive, i.e. non-deprived, PC12 cells
transfected with siRNA targeting the smpd3 gene show a clear de-
crease in nSM2 protein (Fig. 6A, siRNA lanes), in comparison with
non-transfected (Fig. 6A, NT lanes) or transfected cells with control
siRNA (Fig. 6A, Csi lanes). Results show that abrogation of nSM2
expression in PC12 cells impairs basal phosphorylation of Akt in
Ser473 and Thr308, but has no effect on ERK-1/2 phosphorylation,
as can be also observed in the quantiﬁcation of the signals (Fig. 6B).
These results demonstrate that, in unstimulated PC12 cells, Akt
phosphorylation highly depends on basal nSM2.
4. Discussion
The differential effects of neurotrophins on their target cells
rely on a complex array of events, including the balance between
mature and immature neurotrophins and the proportion of Trk to
p75NTR or other co-receptors. In accordance with this, published
evidences suggest an inhibitory activity of Trk receptors on
p75NTR-mediated signaling. A relevant example supporting this
scenario is the NGF-mediated induction of sphingomyelin hydro-
lysis in a p75NTR+/TrkA system, which is abolished by co-expres-
sion of TrkA [25]. On the contrary, in the same work, it is shown
that the inhibition of TrkA activity with K252a enhances p75NTR-
mediated sphingomyelin hydrolysis [25]. Another result support-
ing the inhibition of p75NTR signaling by TrkA is the observation
that TrkA mediates developmental sympathetic neuron survival
in vivo by silencing an ongoing p75NTR-mediated death signal
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Fig. 6. Basal Akt signaling, but not ERK-1/2 signaling, depend on nSMase in PC12
cells. (A) Short interfering RNAs were used to reduce cellular nSM2 levels (siRNA),
while a non-silencing siRNA was used as control (Control siRNA, Csi). Western blots
were used to assess the reduction of nSM2 levels. Non-transfected cells were also
analysed (NT). After knockdown treatment, cell homogenates were resolved in
SDS–PAGE (15 lg of protein per lane) and phosphorylated Akt in Ser 473 and Thr
308, as well as phosphorylated ERK-1/2, were detected by Western blot, in parallel
with total Akt and ERK-1/2. (B) Phosphorylation levels were assessed by image
densitometry and shown as bar graphics (showing percentage respect to NT cells).
Each point represents the mean ± S.D. of three independent experiments. Values
were analyzed using one-way ANOVA, followed by Dunnett’s post hoc test.
⁄⁄⁄P < 0.001.
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a differential cross-regulation of TrkA and of TrkC receptors with
p75NTR has been described, since, in the absence of Trk activation,
the expression of TrkC is permissive of trophic and differentiation
signals induced by p75NTR ligands, which are abolished by the
expression of TrkA [30]. This is in accordance with the observa-
tion that, in contrast to TrkA signaling, p75NTR had a negative ef-
fect on TrkB tyrosine autophosphorylation in response to BDNF or
NT-4/5. On the other hand, p75NTR did not inﬂuence the Ras/mito-
gen-activated protein kinase signaling pathway in BDNF, NT-3, or
NT-4/5 treatments [31]. These results also point to differential
signaling pathways, and thus to a different array of signaling pro-
teins, used by each Trk receptor, in spite of the fact that all of the
Trk receptors share a high homology in sequence and the struc-
ture of the intracellular domain. Another signaling event involved
in NT receptor cross-talk which can be p75NTR-dependent is Akt
phosphorylation, as has been described in human Niemann-Pick
ﬁbroblasts, which lack acidic SMase activity, but not nSMase
activity. Authors found p75NTR-dependent Akt phosphorylation as
being independent of TrkA signaling and depending on PI3-kinase.
Moreover, p75NTR expression increased survival in cells exposed
to staurosporine or subjected to serum withdrawal. These
ﬁndings indicate that p75NTR can facilitate cell survival through
signaling cascades that result in Akt activation [24], although noimplication of SMase activity in this facilitation was described
by the authors. Regarding the role of PI3-kinase in NT receptor
cross-talk, it has been described that this enzyme regulates the
inhibitory signaling between TrkA and p75NTR-dependent sphin-
golipid signaling pathways, and the authors demonstrated the
presence of NGF-dependent interaction between PI3K and acid
SMase localized in caveolae [32]. The same authors described that
caveolae-located TrkA inhibition exists, which is in agreement
with the interaction between TrkA and caveolin and correlates
with an increased ability of NGF to induce sphingomyelin hydro-
lysis through p75NTR [33]. The association of nSM2 with the plas-
ma membrane, as well as with Golgi and recycling compartments,
correlates with the functional link between p75NTR and SMase
activity [34]. The mechanism of SMase activation by p75NTR is un-
known, although a protein related to SMase activation by means
of TNFRI has been described, called FAN, from factor associated
with nSMase activation. FAN is responsible for the stimulation
of nSMase through its binding to a TNFRI region designated
NSD (neutral SMase activation domain) [35]. FAN is also respon-
sible for TNF-induced caspase-3-dependent apoptosis [36], but if
this protein is involved in NT-induced nSMase activity is un-
known. Another protein that is involved in the interaction be-
tween nSM2 and the activating receptor is EED (embryonic
ectodermal development) [37], while calcineurin binds constitu-
tively to nSM2, acting as a sensor of the basal activity of nSM2
[38]. Regarding the mechanism that could explain the functional
antagonism between TrkA and p75NTR, the competition by these
two receptors for the downstream signaling protein p62, also
known as sequestosome-1 or SQSTM1, has been proposed. The
presence or association of TrkA with p75NTR may compete for
p62, a protein that interacts with PKC members of the atypical
family, which is a critical signaling scaffold for the NF-kB activa-
tion pathway [39]. Adaptor protein p62 has been linked to the
extrinsic apoptosis pathway, placing p62 at critical decision
points that control cell death and survival [40]. Pointing also to
NT receptors cross-talk, but this time in the contrary sense, it
has been reported that prolonged treatment (3 h) of PC12 cells
with C2-ceramide induces dimerization and tyrosine phosphory-
lation of TrkA receptors in the absence of NGF [41]. The increase
in ceramide levels is supposed to change membrane conﬁgura-
tion, increasing the content in ceramide platforms, which are con-
sidered to be a subset of the so-called ‘lipid rafts’, which are
membrane microdomains rich in cholesterol and sphingolipids.
Recently, it has been demonstrated that the fragment Hc from
tetanus toxin induces the formation of ceramide platforms and
protects cells from oxidative stress in a nSMase-dependent man-
ner [42]. Regarding the role of SMase activity in cytoprotective
outcome, some metabolites derived from sphingolipid processing
have been involved in Akt signaling, pointing to S1P as a crucial
effector molecule in some events leading to Akt activation [43].
Moreover, studies in hepatocytes showed that TNFa-induced acti-
vations of PI3K and Akt were inhibited by N,N-dimethylsphingo-
sine, an inhibitor of sphingosine kinase (SphK), indicating that
NF-kB, S1P and PI3K/Akt are involved in the signaling that leads
to protection of human hepatocytes from the apoptotic action
of TNFa [44]. In any case, it is clear that, in our system, TrkB-
enhanced Akt phosphorylation is highly dependent on basal nSMase
activity, since no nSMase enhancement is observed in CGN by
BDNF, as seen in Fig. 4B. On the other hand, nSMase blocks the
basal ERK-1/2 pathway but has little effect on the BDNF-en-
hanced ERK-1/2 pathway (Fig. 5). The regulation of neurotro-
phin-triggered Akt and ERK-1/2 pathways has been related to
the protease TACE (TNFa-converting enzyme) action on p75NTR,
since the generation of a proteolysis fragment from p75NTR due
to TACE has been described as necessary for Akt and ERK-1/2 acti-
vation [45]. The breakdown of plasma membrane sphingomyelin
A. Candalija et al. / FEBS Letters 588 (2014) 167–174 173or enrichment of the plasma membrane with ceramide increases
proteolysis (in a mechanism also known as ‘ectodomain shed-
ding’) of another TACE substrate, such as the interleukin-6 recep-
tor (IL-6R) [46]. Thus, according to published data, a model in
which the nSMase-activated TACE contributes to Akt activation
arises, which is in agreement with the nSMase-dependent phos-
phorylation of Akt exerted by the BDNF action in CGN, shown
in the present work, as well as in previous work from our group
[42].
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